Option chain shows key data for Genenta Science's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Genenta Science.

Genenta Science (NASDAQ:GNTA) Stock, Option Chain

Genenta Science

Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ADSK

AGIL

ANGH

ATGL

Alterity Therapeutics Limited - American Depositary Shares

ATHE

ATPC

CNTB

EDSA

GHRS

GNTA

GSX Techedu Inc. American Depositary Shares

GOTU

GYRE

HSCS

MIRA

PXMD

RVYL

SHOT

SPRC

TCON

THAR

URBN

Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.

Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Pre-Market Outlook

AKTX

ALLG

ANPC

ANVS

APGN

AREB

ARQQ

ASAN

AUUD

AYLA

BBIG

CDLX

CDRO

CLAQ

CLVS

CVNA

DICE

EVEX

GSHD

HYPR

IBRX

IDAI

IDYA

IMTX

INLX

KSPN

LCID

LPTX

LSAK

MEGL

MOGU

NRBO

NTCT

NUWE

PIXY

PYPD

RBBN

REBN

RGLS

RMED

RYTM

SGML

STRC

SWTX

TRDA

TUEM

VTNR

VTYX

WETG

YOSH

Gainers


	NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.


Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday

AZRE

SHPH

SPPI

Gainers


	Ventyx Biosciences, Inc.  (NASDAQ: VTYX) shares jumped 70.4% to $39.37 after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.


Why Ventyx Biosciences Is Trading Higher By 70%, Here Are 46 Stocks Moving In Monday&#39;s Mid-Day Session

Genenta Science S.p.A. - American Depositary Shares

Genenta Science SPA

Robert Kiyosaki, businessman and author of Rich Dad, Poor Dad, is once again sounding the alarm about a potential global financial crisis.
What Happened: In a recent post on X, he urged individuals to take action now by investing in gold, silver, and Bitcoin, which he views as essential assets for safeguarding wealth.
Kiyosaki didn't mince words when criticizing the current financial system, labeling the U.S. government, Treasury, and Federal Reserve as a "Den of Thieves." 
His distrust stems from key historical events, such as the 1965 replacement of silver coins with cheaper alloys and President Richard Nixon's 1971 decision to take the U.S. off the gold standard. Kiyosaki believes these actions marked the beginning of a financial system in decline.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">THANK YOU gold, silver and Bitcoin HODLERS: I do not trust the US Giverment, the US Treasury, or the FED. If you trust these Den of Thieves that is your choice. I stopped trusting my government in 1965, when I noticed our silver coins were now alloys of cooper. In 1971…
&mdash; Robert Kiyosaki (@theRealKiyosaki) <a href="https://twitter.com/theRealKiyosaki/status/1870288365150781627?ref_src=twsrc%5Etfw">December 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
A long-time critic of fiat currency, which he calls "fake money," Kiyosaki argues that it exploits the public and erodes wealth. Instead, he advocates for tangible assets like gold, silver, and Bitcoin, which he sees as reliable ways to preserve value during uncertain times. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42255036/kiyosaki-on-bitcoin-100000-almost-impossible-for-the-poor-and-middle-class-to-catch-up">Kiyosaki on Bitcoin $100,000: &#8216;Almost Impossible for the Poor and Middle Class to Catch Up&#8217;</a>
"Protect your wealth by investing in real assets," he advises, emphasizing that these alternatives provide stability against economic volatility.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">OMT One More Thing: As you know our money is fake and our financial leaders are corrupt. For example Trump asked Fed Chairman Powell if he would resign from the Federal Reserve Bank. Powell said "No" just as Biden wants to pardon his son and family from all criminal…
&mdash; Robert Kiyosaki (@theRealKiyosaki) <a href="https://twitter.com/theRealKiyosaki/status/1870317737983250621?ref_src=twsrc%5Etfw">December 21, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
In addition to his investment recommendations, Kiyosaki underscores the importance of financial education. He encourages individuals to learn about money and make informed investment decisions. "Use resources like YouTube to educate yourself," he said, urging people to take control of their financial futures.
As concerns about financial instability grow, Kiyosaki's warnings resonate with many investors seeking to safeguard their wealth. 
His advice to invest in real assets and prioritize financial literacy offers a practical approach to navigating uncertain economic times.
Read Next
<a href="https://www.benzinga.com/news/24/08/40147003/rich-dad-poor-dad-author-robert-kiyosaki-sees-wealth-accumulation-in-market-declines-markets-are-cra">&#8216;Rich Dad Poor Dad&#8217; Author Robert Kiyosaki Sees Wealth Accumulation In Market Declines: &#8216;Markets Are Crashing, Great News, This Is Your Turn To Get Richer&#8217;</a>

Global

Kiyosaki Warns of Global Financial Crisis: 'Protect Your Wealth by Investing in Real Assets'

According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, with mixed sentiment shaping investor outlook for 2025.
Despite strong fundamentals and advancements in drug pipelines, factors such as political uncertainty and sector rotation have hindered the sector's performance relative to the S&amp;P 500.
In 2024, biopharma stocks rose by 9.6%, falling short of the S&amp;P 500's 28.5% surge. However, JP Morgan analysts maintain a positive outlook for several key players.
Eli Lilly And Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), a top pick for the firm, is projected to see continued growth in its diabetes and obesity treatments, <a target="_blank" href="https://www.benzinga.com/general/biotech/24/10/41622207/eli-lilly-q3-earnings-mounjaro-sales-more-than-double-takes-2-98-billion-hit-to-profit-cuts-annua" rel="noreferrer noopener">Mounjaro and Zepbound</a>. The analyst also pointed to the company's robust pipeline and forecasted double-digit revenue and earnings growth into the 2030s.
Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) has been added to JP Morgan's Analyst Focus List due to the strong potential of its schizophrenia drug, Cobenfy, which could achieve peak sales of $10 billion.
Similarly, Merck &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>) and Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) are expected to recover in 2025, following challenges in 2024 related to <a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38208816/eye-drug-eylea-price-manipulation-regeneron-faces-us-justice-department-allegations-over-medicare" rel="noreferrer noopener">competitive pressures </a>and regional dynamics <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40168774/mercks-blockbuster-vaccine-gardasil-sales-in-china-analyst-highlights-challenges-an" rel="noreferrer noopener">affecting key products</a>.
Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>) is poised for growth with the anticipated mid-2025 launch of lenacapavir <a target="_blank" href="https://www.benzinga.com/quote/GILD" rel="noreferrer noopener">for HIV prevention</a>.
The firm also highlighted AbbVie Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) for its appealing valuation, supported by strong Skyrizi and Rinvoq sales despite fewer near-term <a target="_blank" href="https://www.benzinga.com/quote/ABBV" rel="noreferrer noopener">pipeline developments</a>.
Animal health stocks are also projected to rebound in 2025. JP Morgan views Zoetis Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) as the strongest pick in the sector, citing its potential for high single-digit revenue <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41722660/zoetis-q3-earnings-beat-companion-animal-segment-growth-gives-confidence-into-2025-" rel="noreferrer noopener">growth and margin expansion</a>. IDEXX Laboratories, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDXX#NASDAQ">IDXX</a>) is another solid choice, though its performance depends on a r<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41659873/idexx-laboratories-adjusts-guidance-as-q3-revenue-growth-slows-analyst-notes-fewer-" rel="noreferrer noopener">ecovery in veterinary visits</a>. Meanwhile, Elanco Animal Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELAN#NYSE">ELAN</a>) faces uncertainties linked to its <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41817807/elanco-animal-q3-earnings-profit-beat-new-products-and-stabilized-business-to-drive" rel="noreferrer noopener">new product launches</a>.
Specialty pharmaceuticals showed early signs of stabilization in 2024, benefiting from improved pricing stability and supply dynamics. Perrigo Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRGO#NYSE">PRGO</a>) and Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>) are highlighted as promising opportunities, while Teva Pharmaceuticals Industries Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) may face growth challenges despite delivering strong clinical trial <a target="_blank" href="https://www.benzinga.com/general/biotech/24/12/42561832/teva-pharmaceutical-releases-impressive-phase-2-candidate-data-for-gastro-related-diseases" rel="noreferrer noopener">results this year</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42623487/jp-morgan-defensive-oil-stocks-to-watch-in-2025-amid-70-brent-forecast" target="_blank" rel="noreferrer noopener">Defensive Oil Stocks To Watch In 2025 Amid $70 Brent Forecast: JP Morgan</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Biotech

Large Cap

Health Care

Analyst Ratings

General

ABBV

ELAN

GILD

IDXX

PRGO

REGN

TEVA

VTRS

Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More

Victims of the hacking of defunct New Zealand-based crypto exchange Cryptopia are finally seeing restitution, with $225 million in digital assets being distributed to former account holders.
What Happened: The distributions mark a significant milestone in the exchange's liquidation process, which has been ongoing since 2019.
According to the press <a href="https://www.grantthornton.co.nz/press/press-releases-2024/cryptopia-account-holders-receive-%24400m-from-liquidators/">release</a> from accounting firm Grant Thornton, over 10,000 verified users of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) have received their initial cryptocurrency distributions.
"Within the last 48 hours, over $225 million in cryptocurrency has been returned on-chain," the statement reads.
Cryptopia suffered a devastating hack in January 2019, leading to millions of dollars in crypto theft. By May of the same year, the company appointed liquidators, citing the move as being in the "best interests of customers, staff, and other stakeholders."
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39445624/rapper-50-cent-allegedly-caught-in-crypto-scam-defrauding-users-of-300-million-in-just-30-">Rapper 50 Cent Allegedly Caught In Crypto Scam Defrauding Users Of $300 Million In Just 30 Minutes</a>
The liquidators ensured the distribution process adhered to a 2020 court ruling, which declared that digital assets held by Cryptopia are property in the context of liquidation. 
This legal precedent was critical in shaping the current distribution efforts and ensuring fair outcomes for affected users.
The milestone represents a long-awaited step forward for thousands of Cryptopia customers, many of whom have been waiting for years to recover their funds. 
With this progress, the liquidators aim to rebuild trust in the industry and demonstrate the potential for resolution in crypto-related legal cases.
Read Next
<a href="https://www.benzinga.com/markets/cryptocurrency/24/01/36525844/north-korean-hackers-swiped-600-million-worth-of-crypto-in-2023-expected-to-carry-out-more">North Korean Hackers Swiped $600 Million Worth Of Crypto In 2023, Expected To Carry Out More Attacks, Warns Report</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Wikimedia Commons

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

Cryptopia Hack Victims Receive $225 Million In Distributions At Last

NBA great Michael Jordan has finally sold his sprawling mansion in the Chicago suburbs after over a decade on and off the market.
Originally listed in 2012 for $29 million, the nine-bedroom Highland Park estate recently sold for $9.5 million, according to property records. The 56,000-square-foot compound is on seven acres of land down the road from the Chicago Bulls' old practice facility, the Berto Center in Deerfield.
The buyer's identity has not yet been disclosed in public records and appears to have purchased the property without representation by a real estate agent.
Don't Miss:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>
The iconic home, filled with personalized touches <a href="https://www.benzinga.com/startups/24/10/41549835/michael-jordan-the-nbas-first-billionaire-once-bet-100-000-on-a-game-of-rock-paper-scissors-i-enjoy">paying tribute to Jordan</a>, may have contributed to its extended time on the market. In 2015, the asking price was reduced to $14.855 million – a nod to Jordan's legendary jersey number 23, as the digits add up to the iconic number.
The <a href="https://www.benzinga.com/general/sports/24/12/42403470/michael-saylor-uses-lebron-james-michael-jordan-sports-analogy-to-explain-bitcoin-to-dave-portnoy-satoshi-gave-us-a-game-we-can-all-win">former Chicago Bulls star</a>, who hasn't lived there for years, has now officially sold the estate, giving it a new owner after 12 long years.
The mansion, where Jordan lived for 19 years, sold at a steep 67% discount from its original asking price.
See Also: Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.
The median sale price of a home in Highland Park was $729,000, up 19.9% since last year, according to Redfin. On average, homes in Highland Park sell after 56 days on the market, compared to 49 days last year.
"Even at its reduced price, Jordan's home sold for more than the multimillion-dollar homes near Lake Michigan, which rarely sell for more than $5 million," Reddit user wjbc posted on the platform. "As the real estate people say, ‘The top three keys to success in real estate are location, location, location.' If your home is much more expensive than the other homes in the neighborhood, it's usually going to be hard to sell, even if you are Michael Jordan."
Listing agent Katherine Malkin of Compass told The Wall Street Journal that Jordan purchased the property in 1991 and invested about $50 million to build the home.
Trending: During market downturns, investors are learning that unlike equities, these<a href="https://www.benzinga.com/money/connect-invest-real-estate-notes-y2"> high-yield real estate notes that pay 7.5% &#8211; 9% are protected by resilient assets, buffering against losses.</a>
The estate is filled with tributes to Jordan's legendary basketball career, including the number 23 prominently displayed on the front gate, his iconic Air Jordan logo on the full-size indoor basketball court and flagsticks on the putting green.
An infinity pool on the grounds includes a grass island.
Despite creative efforts to sell the property – such as offering a complete set of Air Jordans with the purchase and marketing the home through Mandarin-language videos targeting Jordan's fans in China – the mansion remained unsold and unoccupied for years.
Jordan now divides his time between North Carolina and Jupiter, Florida.
Read Next:
<ul>
<li>CEO of Integris gathered a team of senior investment managers who have $34.22 billion in combined owned and managed assets in the West Coast —<a href="https://www.benzinga.com/money/integris"> here&#8217;s how to invest in their private credit fund that targets 12% annual interest rate.</a></li>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
</ul>

Real Estate

TSLA

From Slam Dunk To Deep Discount – Michael Jordan's Mansion Sells After 12 Years But At How Big Of A Loss?

<a href="https://www.ft.com/content/6cfdfe2b-6872-4963-bde8-dc6c43be5093" title="https://www.ft.com/content/6cfdfe2b-6872-4963-bde8-dc6c43be5093">https://www.ft.com/content/6cfdfe2b-6872-4963-bde8-dc6c43be5093</a>

Contracts

PLTR

Financial Times Reported Sunday, Palantir, Anduril Reportedly Forming Consortium With Competitors To Jointly Bid For U.S. Government Contracts

In a strategic effort to enhance monetization opportunities within the Telegram ecosystem, TON has been working with Adsgram, a dedicated advertising platform tailored for Telegram.
Adsgram emerged from its founder Vadim Sterlin&#8216;s firsthand challenges in monetizing his Fanton game, highlighting a broader issue faced by the GameFi community on Telegram and the TON network.
As a seasoned Adtech product manager, Sterlin highlighted earlier this year in the Adsgram community the scarcity of effective tools for publishers to generate revenue through advertising, underscoring the urgent need for innovative solutions in this space.
Benzinga recently caught up with Sterlin, the CEO and founder of Adsgram. Here's an excerpt from the interaction.   
What factors contributed to Adsgram attracting over 550 mini apps in just six months?
The market required a simple, clear, and scalable solution for monetizing mini-apps, and we were the first to deliver something to meet this growing demand. Our team has a wealth of experience in developing mini-apps, having built one of TON ecosystem's most popular mini-apps in the form of Fanton fantasy football. This gave us unique insights into what developers actually need, and enabled us to refine and optimize the platform for an experience that is as user-friendly as possible.&nbsp; This set us apart from our competitors and helped us to attract many mini-apps to Adsgram during the early stages of our project.
Monetizing Telegram mini-apps has historically been challenging. Individual applications often struggle to connect with advertisers, especially when they're looking to engage larger players in the advertising market. Adsgram filled this gap in the market by offering a unified and seamless solution to help mini apps find new audiences and grow their products.&nbsp;
How does Adsgram tailor advertising specifically for Telegram mini apps compared to traditional ad platforms?
The way that mini-apps bridge Web2 and Web3 is a fascinating aspect of the platform. This position at the intersection of these two worlds opens up exciting opportunities to implement strategies that bridge these two ecosystems. Initially, users were primarily drawn to ads for the rewards they offered in terms of user acquisition. Traffic characteristics and working funnels had to be adjusted, and users had to be educated on how to interact with the new model that we are looking to popularise.&nbsp; Over time, advertisers and users have adapted, creating a mutually beneficial system.&nbsp;
The hallmark of advertising in mini-apps is its simplicity. We intentionally set strict limits on the size of banners and video clips to ensure that any user, on any device, can easily view and engage with the advertising content. A recent innovation we've introduced is the ability for developers to target users by wallet. In addition to traditional targeting options, such as location, language, platform, and premium accounts, focusing on wallet activity grants a deeper understanding of user behaviour in the Web3 space &#8211; this allows advertisers to identify the most financially active and crypto-savvy users within the Telegram ecosystem.
What makes Adsgram attractive to large mobile applications and service providers as advertising partners?
The traffic generated through Telegram Mini Apps (TMA) is not only highly cost-effective but also exceptionally transaction oriented. This is particularly evident when looking at cryptocurrency, where many of the most successful recent projects have leveraged blockchain and airdrop technologies to drive engagement. What sets Adsgram apart is its ability to tap into Telegram's vast audience, which is now close to exceeding one billion users.
How did you identify the need for a dedicated advertising platform within the Telegram mini apps ecosystem?
In 2024, several applications experienced rapid growth, including Notcoin, Hamster Kombat, and Blum. However, all of them relied on inefficient, manual ad sales. This sparked our interest in automating ad sales and building an open, transparent advertising marketplace for Telegram mini-apps. To bring this vision to life, we collaborated with TON Foundation, who believed in our idea and supported the development of Adsgram.
What new features or enhancements can we expect from Adsgram as the mini app space continues to grow? We recently introduced additional targeting options for VPN and wallet users. Further enhancing targeting accuracy and precision will remain a key focus as Adsgram evolves. The market is evolving rapidly, bringing with it new demands for advertising. In response, we've already expanded our platform with several new advertising formats. In the future, we plan to introduce task functionality for our partners. This functionality will help to engage users with our advertising even further, with both the application hosting ads and the user earning crypto rewards for engaging with our product. These tasks will undergo manual moderation, ensuring quality and providing our partners with even more opportunities to earn.

Interview

Targeting Accuracy And Precision Will Remain A Key Focus As Adsgram Evolves, Says Vadim Sterlin

Quantum computing is emerging as a game-changing technology poised to revolutionize industries, much like how <a href="https://www.benzinga.com/general/market-summary/24/12/42569883/quantum-computing-rigetti-d-wave-skyrocket-up-to-300-in-5-sessions-after-google-unveils-willow-chip-but-analysts-urge-caution-not-every-tiktok-guitarist-is-the-next-taylor-swift" target="_blank" rel="noreferrer noopener">artificial intelligence (AI) has transformed the digital landscape</a>.
As we head toward 2025, experts predict that quantum computing will be the next major frontier in tech, unlocking unprecedented computational power and driving breakthroughs in fields such as cryptography, drug discovery, and optimization.
At the heart of quantum computing's potential is the quantum bit, or qubit, which can represent multiple states simultaneously, allowing quantum computers to process data exponentially faster than classical computers. In fact, recent advancements have already shown the immense promise of this technology.
For example, Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)
Quantum AI division, led by Hartmut Neven, recently unveiled its <a href="https://www.benzinga.com/tech/24/12/42397333/google-quantum-ais-new-willow-chip-can-do-in-minutes-that-supercomputers-would-take-10-septillion-years" target="_blank" rel="noreferrer noopener">latest quantum chip, Willow</a>. This chip reduces errors exponentially and completed a benchmark computation in under five minutes—an operation that would have taken one of the fastest supercomputers 10^25 years to finish.
The rise of quantum computing presents a compelling complement to AI, as it has the potential to enhance AI models and algorithms, helping unlock entirely new frontiers in science and technology. As this technology advances, it could usher in a new wave of innovation, particularly in industries reliant on complex data processing and problem-solving.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/24/12/42380768/quantum-computing-stocks-roundup-d-wave-rigetti-ionq-lead-the-charge-with-explosive-growth" rel="noreferrer noopener">Quantum Computing Stocks Roundup: D-Wave, Rigetti, IonQ Lead the Charge With Explosive Growth</a>
Market Growth and Investment Opportunities
The quantum computing market is set for explosive growth. According <a href="https://www.fortunebusinessinsights.com/u-s-quantum-computing-market-107727" target="_blank" rel="noreferrer noopener">to</a> Fortune Business Insights, the U.S. quantum computing market, valued at $138.2 million in 2022, is projected to skyrocket to $1.2 billion by 2030, growing at a CAGR of 31.7%. 
This surge is driven by increasing investment and initiatives like those outlined by the White House in May 2022.
For investors looking to capitalize on this booming sector, top companies include Top stocks to invest:
<ul>
<li>NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</li>
<li>Honeywell International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HON#NASDAQ">HON</a>)</li>
<li>Microsoft Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</li>
<li>International Business Machines Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>)</li>
<li>IonQ, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>)</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>)</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>)</li>
<li>D-Wave Quantum Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>)</li>
</ul>
Quantum-focused ETFs offer a diversified approach to investing in this transformative space. Per Rising Wave, <a target="_blank" href="https://risingwave.com/blog/top-quantum-computing-etfs-for-growth/" rel="noreferrer noopener">investing</a> in quantum computing ETFs offers a distinctive chance to participate in a technological revolution.
<ul>
<li>Defiance Quantum ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QTUM#NASDAQ">QTUM</a>)</li>
<li>WisdomTree Cloud Computing Fund (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WCLD#NASDAQ">WCLD</a>)</li>
<li>Global X Cloud Computing ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLOU#NASDAQ">CLOU</a>)</li>
<li>ARK Next Generation Internet ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)</li>
</ul>
As quantum computing approaches mainstream adoption, it will likely become one of the most exciting areas of growth in the tech industry over the next few years.

Equities

Tech

ARKW

CLOU

GOOG

GOOGL

IONQ

MSFT

NVDA

QBTS

QTUM

QUBT

RGTI

WCLD

Quantum Computing: The New AI? A Look at the Rapidly Expanding Market and Top Stocks For 2025

As we are amid the holiday chaos and joy, hunting down presents at the last minute before getting together with our families, financial expert <a href="https://www.benzinga.com/personal-finance/24/12/42500258/have-more-than-you-need-dont-waste-it-suze-orman-reveals-how-ira-charitable-gifts-can-cut-taxes-and-shrink-your-rmds">Suze Orman</a> strongly warns about the dangers of buying gifts with credit cards. On a <a href="https://omny.fm/shows/suze-ormans-women-and-money/suze-school-are-you-in-financial-panic-mode">recent episode</a> of her Women &amp; Money podcast, Orman cautioned listeners against letting financial guilt or societal pressures lead them into debt during the season of giving.
Orman discusses how many people carefully manage their finances throughout the year only to undo that progress in December. She refers to the last ten days before <a href="https://www.benzinga.com/personal-finance/24/12/42317960/warren-buffett-used-to-gift-loved-ones-10000-cash-for-christmas-but-switched-to-stocks-with-a-note-cash-them-in-or-hold-onto-them">Christmas</a> as &#8220;G-Day&#8221; or &#8220;Gift Day,&#8221; when financial guilt and holiday spirit often lead to impulsive spending.
Don't Miss:
<ul>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
&#8220;You only went in there to spend maybe $50…and before you know it, you walk out with, typically, by the way, around $600 or $700 worth of items,&#8221; Orman explains. She adds that people think they are saving with the discounts that retailers offer around this time but in reality, most people spend way more and even go into debt.
Using hypothetical scenarios, Orman outlines how small credit card purchases can snowball into significant debt. For instance, charging $1,000 for holiday gifts on a credit card with a 28% interest rate can take over nine years to pay off if only minimum payments are made. The total cost? Nearly $3,000 when factoring in interest.
According to Orman, the average American carries $6,329 in <a href="https://www.benzinga.com/24/11/42013422/credit-card-balances-rise-as-delinquencies-falls-the-latest">credit card debt</a>, with an average interest rate of 23.37%. At these rates, paying only the minimum due can take more than 21 years to clear the balance, costing thousands of dollars in interest.
See Also: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
"You are not being generous to yourself," Orman said about those left with credit card debt after the holidays. "You are financially sabotaging your future."
A MarketWatch survey found that 67% of Americans use credit cards for holiday gifts. About 12% of those surveyed said they are still paying off their balances from last year's shopping.&nbsp;
Orman also reflects on her experiences visiting homes during her time on <a href="https://www.benzinga.com/personal-finance/24/07/39693693/suze-orman-tells-oprah-instead-of-starbucks-everyday-a-25-year-old-putting-100-a-month-into-roth">The Oprah Winfrey Show</a>. She often found closets filled with unused gifts that recipients didn't like but felt guilty returning. &#8220;You wasted their money by taking this gift under the pretense that you loved it,&#8221; she told those who kept the gifts. Even well-intentioned purchases can create emotional and financial burdens if they are not truly needed or appreciated.
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
To Orman, real generosity means giving in a way that doesn't jeopardize your financial health. She advises only buying gifts with cash—and only if you have no existing credit card debt, a fully funded emergency fund and adequate retirement savings.
If those conditions aren't met, Orman suggests finding creative, cost-free ways to show love and appreciation. Honesty about your financial limitations can inspire mutual understanding and strengthen relationships.
Orman's message is clear: buying gifts with credit cards, especially when you're already in debt, is a form of self-sabotage. She encourages listeners to think beyond the fleeting joy of holiday giving and focus on the long-term impact on their <a href="https://www.benzinga.com/personal-finance/24/10/41555075/millennials-and-gen-z-rely-on-parents-for-financial-support-survey-finds-its-costing-them-their-">financial future</a>.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
</ul>

Personal Finance

Suze Orman Says If You Buy Someone A Gift On A Credit Card, 'You Are Financially Sabotaging Your Future'

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is reportedly developing a smart doorbell camera with Face ID technology that could unlock doors using facial recognition. 
According to Bloomberg's Mark Gurman in his &#8220;Power On&#8221; newsletter, the innovative device may be released by the end of 2025 "at the soonest."
The smart lock system would function similarly to an iPhone, unlocking doors when a registered user or resident is recognized by the camera. Apple plans to integrate its Secure Enclave chip, which securely stores and processes Face ID data separately from other hardware, ensuring high security.
In his <a href="https://www.bloomberg.com/news/newsletters/2024-12-22/apple-explores-amazon-ring-doorbell-competitor-with-face-id-airpods-heart-rate?srnd=undefined&amp;sref=TBDibEcD">post</a>, Gurman suggests that the device will likely work with third-party HomeKit-enabled smart locks. Apple may also partner with a smart lock manufacturer to deliver a complete system at launch. 
Additionally, the doorbell camera is expected to utilize Apple's in-house "Proxima" chip, a Wi-Fi and Bluetooth combination set to feature in upcoming HomePod Mini and Apple TV models next year.
Also Read: <a href="https://www.benzinga.com/tech/24/12/42500167/could-apple-set-revolutionize-tablet-market-with-18-8-inch-foldable-ipad">Could Apple Set Revolutionize Tablet Market With 18.8-Inch Foldable iPad?</a>
&#8220;Also next year, Apple will roll out upgrades to existing home devices: its TV set-top box and HomePod mini smart speaker. That will add an advanced&nbsp;wireless chip dubbed Proxima&nbsp;and better support the new Thread standard for wirelessly linking products in the home,&#8221; Gurman wrote in the post. 
This doorbell camera is part of Apple's broader push into smart home technology under its Apple Intelligence initiative. Rumored products include new smart home cameras, an Apple-branded TV, and smart displays. 
These displays are said to include an iPad-like device that attaches magnetically to wall mounts or speaker bases and another equipped with a robotic arm for enhanced flexibility.
Apple's continued expansion into smart home solutions signals its commitment to creating a cohesive ecosystem of devices designed to enhance daily life with seamless integration and advanced security.
Read Next
<a href="https://www.benzinga.com/news/24/08/40429457/apples-tabletop-robot-the-future-of-home-technology-or-a-potential-misstep" target="_blank" rel="noreferrer noopener">Apple&#8217;s Tabletop Robot: The Future Of Home Technology Or A Potential Misstep?</a>

AAPL

Apple Developing Face ID Smart Doorbell To Unlock Doors By Late 2025

Elon Musk, the richest person in the world, has reached a <a href="https://www.benzinga.com/markets/equities/24/12/42435201/elon-musks-net-worth-surpasses-market-cap-of-us-giants-like-bofa-johnson-johnson-salesforce-chevron-coca-cola-and-more-only-25-companies-have-higher-market-cap">level of wealth</a> that only one other individual in history has come close to – oil magnate <a href="https://www.benzinga.com/personal-finance/24/03/37792386/warren-buffett-says-even-the-bottom-2-of-earners-all-live-better-than-john-d-rockefeller-and-he-">John D. Rockefeller</a>.
Musk&#8217;s staggering net worth of $474 billion at the time of writing, or 1.61% of the U.S. GDP based on <a href="https://www.bea.gov/sites/default/files/2024-11/gdp3q24-2nd.pdf">third-quarter data</a>, is reminiscent of Rockefeller&#8217;s dominance when his fortune peaked at 1.5% of GDP. In other words, Musk's wealth has surged into a realm not seen in contemporary times, much like Rockefeller&#8217;s unparalleled economic influence more than a century ago.
<figure class="wp-block-embed is-type-video is-provider-tiktok wp-block-embed-tiktok"> 
<div class="wp-block-embed__wrapper">
<blockquote class="tiktok-embed" cite="https://www.tiktok.com/@realestatebulldog/video/7448011483935558958" data-video-id="7448011483935558958" data-embed-from="oembed" style="max-width:605px; min-width:325px;"> <section> <a target="_blank" title="@realestatebulldog" href="https://www.tiktok.com/@realestatebulldog?refer=embed">@realestatebulldog</a>
Who&#8217;s hungry? <a title="eattherich" target="_blank" href="https://www.tiktok.com/tag/eattherich?refer=embed">#eattherich</a> 
 <a target="_blank" title="♬ original sound - Whisper Pickle" href="https://www.tiktok.com/music/original-sound-7448011462465571626?refer=embed">♬ original sound &#8211; Whisper Pickle</a> </section> </blockquote>
<script async src="https://www.tiktok.com/embed.js"></script></div>
</figure>
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
</ul>
‘
Tesla's recent stock surge largely fuels Musk's fortune. Tesla's stock price has risen 86% this year, hitting record highs after Donald Trump won the 2024 election. Experts believe Tesla could perform even better under Trump's administration due to policies expected to support self-driving cars and reduce tax credits that benefit Tesla's competitors.
According to <a href="https://www.benzinga.com/general/education/24/01/36454392/worlds-top-10-richest-people-gained-more-wealth-in-2023-than-walmarts-total-value-how-elon-musk">Bloomberg&#8217;s year-end valuation of $229 billion</a>, Musk gained $245 billion in 2024 alone. This is so massive that it exceeds the combined net worth of all but two other billionaires: Mark Zuckerberg ($221 billion) and Jeff Bezos ($251 billion).
John D. Rockefeller, the founder of Standard Oil, was the original "world's richest man." By his death in 1937, his net worth stood at $1.4 billion, representing 1.5% of the <a href="https://www.hbs.edu/faculty/Pages/item.aspx?num=47167">U.S. GDP</a>.
See Also: Deloitte's fastest-growing software company partnered with Amazon, Walmart &amp; Target announces the deadline to invest this year is 12/20. – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a>
Rockefeller's wealth came from his near-total control of the oil industry, which powered the Industrial Revolution. His company, Standard Oil, controlled 90% of U.S. oil refining. Standard Oil, however, was split up into 34 companies in 1911 due to public outcry and judicial scrutiny; several of these businesses, like ExxonMobil and Chevron, continue to dominate the oil industry today.
While Musk&#8217;s income comes from cutting-edge industries like space exploration, electric cars, and artificial intelligence, Rockefeller&#8217;s fortune came from an indispensable resource – oil – that characterized an entire era. Yet, both men represent a financial dominance that's hard to fathom.
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a>
Here&#8217;s a comparison to grasp how large Musk's fortune really is. All NFL, NBA, MLB, and NHL teams combined are valued at $433.57 billion. Musk could theoretically <a href="https://www.benzinga.com/general/sports/24/12/42521401/elon-musk-is-so-rich-he-could-buy-every-mlb-nba-nfl-nhl-team-and-still-have-cash-left-over">buy every professional sports team</a> in North America and still have over $43 billion left over.
Musk's wealth may keep growing. The Trump administration's <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42046316/trump-set-to-hand-musk-golden-path-for-tesla-after-reversing-course-on-autonomous-vehicle-ban">potential policies</a> supporting self-driving vehicles and limiting EV tax credits for competitors could directly benefit Tesla. SpaceX also seems to be gaining from future government contracts, especially with Trump nominating Jared Isaacman – a SpaceX investor and friend of Musk – to lead NASA.
However, Musk still faces challenges. A <a href="https://www.benzinga.com/24/12/42495275/elon-musk-can-now-appeal-to-restore-56-billion-pay-package-from-tesla-report">legal battle</a> over his 2018 Tesla pay package could impact his fortune if courts uphold the recent ruling against it.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones.  <a href="https://www.benzinga.com/money/mode-mobile-2">The deadline to invest and receive your shares this year is 12/20. Join 30,000+ shareholders and invest at $0.26/share today.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

'Rockefeller Rich' – Elon Musk's Wealth Hits 'Rockefeller Rich' Levels, Equivalent To A 1.6% Share Of The U.S. GDP

Michael Saylor&#8216;s MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) fell in the last five sessions amid heightened volatility due to concerns over hurdles in its S&amp;P 500 inclusion and falling Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42560698/microstrategys-aggressive-bitcoin-strategy-raises-eyebrows-in-crypto-community">prices</a>.
What Happened: While MicroStrategy meets the S&amp;P 500&#8217;s market capitalization and trading volume benchmark requirements, it doesn&#8217;t fulfill the earnings criteria, said Benchmark, according <a href="https://in.investing.com/news/analyst-ratings/benchmark-keeps-buy-rating-on-microstrategy-stock-cites-nasdaq-inclusion-93CH-4577084">to</a> a report by Investing.com.
In order to be listed on the S&amp;P 500, a company is required to have positive earnings in the latest quarter. Additionally, the listing criterion states that it should have had positive earnings in the preceding four quarters, as well.
The company also faces an issue wherein its Bitcoin holdings cannot be accounted for in its financial statements. Benchmark analyst Mark Palmer says that MicroStrategy is poised to adopt new Financial Accounting Standards Board guidelines for Bitcoin accounting in Q1 2025.
This change is anticipated to immediately boost the company&#8217;s earnings, potentially aligning it with the S&amp;P 500&#8217;s inclusion standards.
By meeting these criteria, MicroStrategy could significantly broaden its investor base. This includes institutional investors and index funds tracking the S&amp;P 500, which could increase demand for the company&#8217;s stock.
See Also: <a href="https://www.benzinga.com/24/12/42610958/expecting-up-to-four-fed-rate-cuts-in-2025-says-this-analyst-despite-hawkish-powell-saying-it-was-close-on-the-decision-to-cut-or-not-heres-why">Hawkish Powell Aside, This Analyst Expects 4 Fed Rate Cuts In 2025: Here&#8217;s Why</a>
Why It Matters: MicroStrategy stock closed 14.44% lower over the last five sessions at $364.20 on Friday, according to Benzinga Pro data.
For context, Bitcoin has fallen by 9.95% to $93,912.90 over the last five days. Whereas, iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) dropped by 4.32% in the same period.
MicroStrategy now controls nearly 2.1% of the total Bitcoin supply.
Benchmark has assigned a &#8220;Buy&#8221; rating to the company with a $650 price target. This valuation is derived from a sum-of-the-parts analysis, factoring in the potential value of the company&#8217;s Bitcoin holdings in 2026. They anticipate a Bitcoin price of $225,000 by the end of that year.
Despite the challenges with S&amp;P 500 inclusion, the shares of the company will be listed on the Nasdaq 100 on Monday, Dec. 23. This is possible because companies eligible for inclusion are primarily chosen according to their market capitalization ranking on the last trading day of November.
What Are Other Analysts Saying: About 12 <a href="https://www.benzinga.com/quote/MSTR/analyst-ratings">analysts tracked by Benzinga</a> have a consensus &#8220;Buy&#8221; rating on the stock with a price target of $449.5 per share.
The three most-recent analyst ratings between Bernstein, TD Cowen, and Barclays imply a 76.82% upside for MSTR.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/MSTR/analyst-ratings"><img loading="lazy" decoding="async" width="949" height="352" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20081405/MSTR-ANR.png" alt="" class="wp-image-701675" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20081405/MSTR-ANR.png 949w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20081405/MSTR-ANR-300x111.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/20081405/MSTR-ANR-768x285.png 768w" sizes="(max-width: 949px) 100vw, 949px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42610441/nikes-new-ceo-says-we-lost-our-obsession-with-sport-as-he-rebukes-old-strategies-on-performance-marketing-isolation-of-wholesalers-aims-to-create-demand">Nike&#8217;s New CEO Blames Promotions For Declining Profits, Says Turnaround Efforts May Hurt As Company Moves To Clear Excess Inventory: &#8216;We Lost Our Obsession With Sport&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

IBIT

MSTR

MicroStrategy Stock Declines Over 14% Amid Heightened Volatility Over S&P 500 Inclusion Concerns: Here's What Is Happening

At 79, Dan Weiss has found an unconventional way to stay active, earn a solid income and connect with people – <a href="https://www.benzinga.com/money/best-websites-to-make-money-online">assembling furniture on TaskRabbit</a>. The retired mortgage manager from Oakdale, Minnesota, earns up to $47 an hour putting together Ikea and other types of furniture, a gig that he says brings in $3,000 to $5,000 a month.
Dan told Business Insider that he retired in 2014 after decades of managing residential mortgage branches. At first, retirement seemed like a well-earned break, but it didn't take long for him to feel the absence of structure in his daily life. "Going from 100 mph to 0 was very abrupt," Dan says. "One can only do so much gardening and reading without feeling unfulfilled."
Don't Miss:
<ul>
<li>The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a></li>
<li>Deloitte's fastest-growing software company partnered with Amazon, Walmart &amp; Target announces the deadline to invest this year is 12/20. – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
After six months of traditional retirement, he sought something to keep himself busy while avoiding dipping too heavily into his savings. Over the years, Dan tried part-time jobs at Costco, customer service roles and <a href="https://www.benzinga.com/news/24/05/38613581/uber-and-lyft-drivers-future-hangs-in-balance-as-massachusetts-supreme-court-deliberates">driving for Uber and Lyft</a> before reading about TaskRabbit in a local newspaper. Intrigued, he signed up and quickly discovered a gig he enjoyed.
Since joining TaskRabbit in 2021, Dan has completed nearly 1,200 tasks and made over $47,000 in 2023 alone. On a typical week, he handles one to three daily tasks four to five days a week, often traveling within 30 minutes of his home.
His clients come from all walks of life and the variety keeps things interesting. Beyond the income, Dan appreciates the social aspect. "I meet people from all walks of life and find their stories interesting. I enjoy this aspect of tasking the most," he told BI.
See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">Retirement Regrets and Realizations</h2>
Like many retirees, Dan has wrestled with the financial and emotional challenges of leaving the workforce. According to Nationwide&#8217;s Protected Retirement Survey, 82% of Americans over 45 <a href="https://www.benzinga.com/general/education/24/12/42499922/americans-regret-retirement-prep-as-advisors-rethink-2025-strategies">regret not taking retirement planning seriously earlier</a>. While he's glad his TaskRabbit income supplements his savings, he's also aware that better planning might have eased some of the pressure.
Dan's advice for retirees? Find something you love to do and stay adaptable. Whether it's assembling furniture, volunteering or pursuing hobbies, the key is maintaining a sense of purpose and structure.
Dan plans to keep working on TaskRabbit as long as his body allows. His earnings have funded trips with his wife, including visits to their favorite destination, Maui. He's also exploring other potential adventures as he stays active in his later years.
Read Next:
<ul>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> you can become an investor for $0.80 per share today.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones.  <a href="https://www.benzinga.com/money/mode-mobile-2">The deadline to invest and receive your shares this year is 12/20. Join 30,000+ shareholders and invest at $0.26/share today.</a></li>
</ul>

TaskRabbit At 79? A Retired Mortgage Manager Assembles Furniture For $47 An Hour, Pulling In $3,000 To $5,000 A Month

Crypto analyst Anthony Pompliano, founder of Pomp Investments, remains optimistic about Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) despite its recent drop below the $100,000 milestone. 
What Happened: In a recent interview with FOX 5, Pompliano predicted that "2025 will continue to be a great year for Bitcoin."
Pompliano outlined two key factors driving Bitcoin's future growth. "One, you're going to continue to get printing of money both in the United States and globally. And then two is you have a Federal Reserve that is cutting interest rates," he said. 
During the <a href="https://www.youtube.com/watch?v=sjqw8hGkDL8">interview</a>, he shared that the increasing M2 money supply and cheaper capital from lower interest rates are likely to fuel market gains. 
Pompliano also discussed why Bitcoin's growth and market cap expansion have made it more attractive to institutional investors. 
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42380983/this-analyst-says-bitcoin-could-reach-200k-by-end-of-2025">This Analyst Says Bitcoin Could Reach $200K By End of 2025</a>
"When Bitcoin was at $1,000, large capital pools viewed it as too small and risky," he explained. However, Bitcoin's rise to a $2 trillion market cap has changed perceptions. "Now all of a sudden everyone's like, ‘Wait a second, I can put money in it. It's derisked.'"
He noted that as Bitcoin's price climbs, more institutional capital is likely to flow into the asset. "As large pools of capital come in to buy a finite-supply asset, price should continue to go up," Pompliano said, emphasizing Bitcoin's limited supply as a key driver of its long-term value.
Despite its recent volatility, Pompliano's outlook underscores the growing institutional acceptance of Bitcoin and its potential to achieve greater heights as a premier digital asset.
At the time of writing Bitcoin was trading at $95,805.13, down by almost 2 per cent in the last seven days. 
Read Next
<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/42155010/bitcoins-bull-run-betting-on-a-125k-finish-to-2024" target="_blank" rel="noreferrer noopener">Bitcoin's Bull Run: Betting On A $125K Finish To 2024</a>

Crypto Analyst: '2025 Will Continue To Be a Great Year for Bitcoin'

From high fashion to high-rises – developers have cottoned on to the fact that their high-net-worth clientele is a brand-centric crowd, shopping for labels and status symbols as most people shop for groceries. That&#8217;s why, increasingly, luxury residential buildings have leveraged exclusive retail brands to help sell their units. Unsurprisingly, nowhere is this more popular than at the crossroads of the catwalk and condo – <a href="https://www.benzinga.com/content/42467692/dinner-of-the-year-art-week-miami-2024-blended-exceptional-art-exclusive-fashion-and-engaging-philan">Miami</a>.&nbsp;
Don't Miss:
<ul>
<li>These five entrepreneurs are worth $223 billion –<a href="https://www.benzinga.com/money/arrived-homes-private-credit-fund"> they all believe in one platform that offers a 7-9% target yield with monthly dividends</a></li>
<li>Deloitte's fastest-growing software company partnered with Amazon, Walmart &amp; Target announces the deadline to invest this year is 12/20. – <a href="https://www.benzinga.com/money/mode-mobile-2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
<h2 class="wp-block-heading">Dolce &amp; Gabbana</h2>
The Dolce &amp; Gabbana branded 888 Brickell will see a new 90-story, 1,049 ft super tall condo tower – a record for Miami – take to skies, comprising 259 residences and a yet-to-be-announced 5-star hotel. What is the fashion brand&#8217;s contribution to the development besides their coveted name? D&amp;G&#8217;s famous gold and black design style will abound throughout the building. The facade will feature ivory travertine, white stucco and matte black steel beams; at the street level, the building features a necklace of golden beads courtesy of New York architecture practice Studio Sofield. The design team said they were inspired to invoke &#8220;quintessential modernist skyscrapers and Milanese midcentury design and fashion.&#8221;
D&amp;G&#8217;s actual input was that their designers collaborated with Milan-based studio M2Atelier on the interiors for the project. Renderings depict dark, moody public spaces outfitted with metallic highlights and animal-print furniture.
See Also: It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a>
<h2 class="wp-block-heading">Elle Residences</h2>
Not to be outdone, Elle Residences (as in the women&#8217;s fashion/lifestyle magazine), Miami, at 3618 NE 5th Ave. in Edgewater, is a 180-unit project developed by Urban Network Capital Group and Vertical Developments. It will feature interiors by The One Atelier (a design company with a long pedigree of branded buildings, including those by Fendi and Karl Lagerfeld).&nbsp;
&#8220;This groundbreaking residential project will debut a new legacy for Elle, one of which we are proud to share in the next chapter of this influential brand,&#8221; Fernando de Nuñez y Lugones, CEO of Vertical Developments, said in a statement. &#8220;Our aspiration is not just to build a tower but create an ownership experience that amplifies modernity with the timeless sophistication of Elle&#8217;s nearly 80-year history.&#8221;
Aside from the slew of top-notch amenities and the instantly recognizable name value, buyers willing to shell out high six figures and up will want to know what distinguishes Elle and other name brands from their competition.
Trending: Unlock the hidden potential of commercial real estate —<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a>
&#8220;This project will represent a groundbreaking concept, offering captivating gateways for owners and residents to experience condo living through a fresh lens and the visionary perspective of Elle,&#8221; <a href="https://robbreport.com/shelter/new-construction/elle-branded-residences-miami-1235628190/">Constance Benqué</a>, CEO of Elle International and Lagardère News, said.
This may be a vague summation, but the fact is that a famous name brand is the magical pixie dust that can make a consumer choose it over the competition. It leverages the brand&#8217;s history, credibility and lifestyle and transfers it to the building. <a href="https://www.benzinga.com/tech/24/11/42033401/porsche-recalls-nearly-16k-taycan-evs-in-china-citing-fire-risk">Porsche</a>, Aston Martin, <a href="https://www.benzinga.com/24/05/38819007/mercedes-worker-advocates-for-better-work-life-balance-amid-unionization-efforts-in-alabama-plant-so">Mercedes</a>, Bentley, Pagani, Armani and Fendi are well-known brands attached to Miami condos.
<h2 class="wp-block-heading">A City Of Brands</h2>
&#8220;It&#8217;s nothing short of wild how many branded developments there are,&#8221; Peter Bazeli, a real estate development advisor and principal at consultancy Weitzman, told Curbed. &#8220;Now it&#8217;s expected,&#8221; Bazeli said. &#8220;The traditional residential model of just building a really nice building is not enough anymore. Each new development has to have a brand, has to conjure up the idea of what the lifestyle can be.&#8221;
But why Miami and not New York or LA? In those cities, the location itself is the brand. In Miami, where city locations are not well known, branding makes good business sense, especially to International buyers, even if the brand&#8217;s involvement beyond lending its name is questionable.&nbsp;
Read Next:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Dolce & Gabbana and Elle Magazine Are The Latest Branded Condos To Hit Miami. Here's Why They Make Such Good Business Sense

America's wealthiest billionaires have witnessed an extraordinary year in 2024, with their fortunes far outpacing the 3% growth of the U.S. economy. 
What Happened: Surging markets, fueled by advancements in technology and artificial intelligence, have propelled their wealth to unprecedented levels. 
According to the report <a href="https://www.thedailybeast.com/these-ten-people-made-796b-in-this-years-tech-stock-surge/">by</a> The Daily Beast, these top 10 billionaires amassed gains nearly equivalent to the U.S. government's annual defense budget of $850 billion.
<h3 class="wp-block-heading">10. Michael Dell: $14 Billion</h3>
The founder of Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) saw a 55% surge in his company's stock this year, thanks to its transformation into an infrastructure powerhouse for the AI age. Dell owns approximately half of the company, contributing significantly to his fortune.
<h3 class="wp-block-heading">9. Larry Page and Sergey Brin: $19–20 Billion</h3>
The Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) founders benefited from the company's $650 billion valuation increase in 2024. Despite stepping back from operations, they retain control through super-voting shares, owning just over 3% each of the tech giant.
<h3 class="wp-block-heading">8. Steve Ballmer: $20 Billion</h3>
The former Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) CEO continues to profit from the company's revival under Satya Nadella. Ballmer owns 4.5% of Microsoft, which has funded ventures such as a new stadium for the LA Clippers, the NBA team he owns.
<h3 class="wp-block-heading">7. Warren Buffett: $29 Billion</h3>
Through Berkshire Hathaway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), Buffett continues to outperform the market. The company's value rose 28% this year, helping Buffett build his cash reserves to an impressive $325 million, or 30% of Berkshire's valuation.
<h3 class="wp-block-heading">6. Jeff Bezos: $63 Billion</h3>
Bezos, the founder of Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), saw his wealth soar by over $1 billion weekly as Amazon stock rebounded. Bezos retains nearly 9% of the company, funding projects like Blue Origin through periodic stock sales.
Also Read: <a href="https://www.benzinga.com/news/24/02/37059392/from-steve-ballmer-to-jamie-dimon-meet-the-billionaires-who-amassed-their-wealth-without-founding-a">From Steve Ballmer To Jamie Dimon, Meet The Billionaires Who Amassed Their Wealth Without Founding A Company</a>
<h3 class="wp-block-heading">5. Jensen Huang: $72 Billion</h3>
The founder of Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) reaped immense gains as the company became the darling of the AI revolution. Nvidia's value more than doubled in 2024, with Huang's 3.8% stake driving his fortune.
<h3 class="wp-block-heading">4. Larry Ellison: $73 Billion</h3>
The Oracle founder's fortune grew alongside the company's role as a key player in cloud computing. Ellison owns 43% of Oracle, benefiting significantly from the AI-driven surge in enterprise demand.
<h3 class="wp-block-heading">3. Mark Zuckerberg: $82 Billion</h3>
Zuckerberg's Meta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) saw its value rise more than sixfold since late 2022, thanks to strong margins and AI developments like the Llama open-source model. His 13.5% stake in Meta underpins his staggering gains.
<h3 class="wp-block-heading">2. The Waltons: $148 Billion</h3>
America's richest family, heirs to Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>), collectively control the fortune built by Sam Walton. Their wealth solidifies Walmart's status as one of the largest employers in the country.
<h3 class="wp-block-heading">1. Elon Musk: $252 Billion</h3>
The Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and SpaceX founder tops the list with his fortune growing by nearly $5 billion weekly. Musk's ventures, including Neuralink, the Boring Company, and his federal government initiatives, further cement his status as the most influential figure in business.
Read Next
<a href="https://www.benzinga.com/news/23/06/32705841/billionaires-paradise-new-york-tops-the-list-of-16-cities-housing-the-worlds-richest" target="_blank" rel="noreferrer noopener">Billionaires&#8217; Paradise: New York Tops The List Of 16 Cities Housing The World&#8217;s Richest</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image: Shutterstock

Success Stories

AMZN

DELL

Tech Titans Triumph: The Top 10 Billionaires Who Made Big Gains In 2024

These eleven large-cap stocks were the worst performers in the last week. Are they in your portfolio?
<ol>
<li>Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) shares dipped 20.52% after the company released headline results from the REDEFINE 1 Phase 3 <a href="https://www.benzinga.com//node/42613036" target="_blank" rel="noreferrer noopener">trial in the global REDEFINE program</a>.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) stock declined 14.33% after the company announced results from its <a href="https://www.benzinga.com//node/42599745" target="_blank" rel="noreferrer noopener">Phase 2 study of Suzetrigine</a>.</li>
<li>XPO, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPO#NYSE">XPO</a>) shares were down 13.47%.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) shares fell 13.33% last week as the company is <a href="https://www.benzinga.com//node/42520765" target="_blank" rel="noreferrer noopener">set to be removed</a> from the Nasdaq 100 Index.</li>
<li>Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) stock plummeted 13.07%. A new government fiscal spending package and last week&#8217;s central bank rate hike could erode global investor confidence and raise concerns over the nation&#8217;s deficit.</li>
<li>Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) stock was down 13.01%, likely due to continued weakness stemming from its <a href="https://www.benzinga.com//node/42538739" target="_blank" rel="noreferrer noopener">ongoing legal dispute</a> with Qualcomm Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>).</li>
<li>Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) shares decreased 12.08% after the company reported mixed earnings results and issued weak guidance for the current quarter. <a href="https://www.benzinga.com//node/42594359" target="_blank" rel="noreferrer noopener">Multiple analysts also lowered price forecasts</a>.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) stock lost 11.63% last week, a result of the Fed rate decision that caused a selloff in software stocks.</li>
<li>Cintas Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTAS#NASDAQ">CTAS</a>) stock declined 11.50% after the company reported <a href="https://www.benzinga.com//node/42588404" target="_blank" rel="noreferrer noopener">second-quarter financial results</a>. Several analysts lowered <a href="https://www.benzinga.com/quote/ctas/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) <a href="https://www.benzinga.com//node/42603589" target="_blank" rel="noreferrer noopener">declined 11.43%</a>.</li>
<li>monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) stock dived 11.20% after Citigroup cut its price forecast <a href="https://www.benzinga.com/quote/mndy/analyst-ratings" target="_blank" rel="noreferrer noopener">on the stock from $338 to $302</a>.</li>
</ol>
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/12/42638256/teva-pharmaceutical-li-auto-and-darden-restaurants-are-among-top-large-cap-gainers-last-week-december-16-20-are-the-others-in-your-portfolio" target="_blank" rel="noreferrer noopener">Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?</a></li>
</ul>
Photo via Shutterstock

CTAS

MNDY

PAYC

QCOM

SMCI

VRTX

Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?

It's that time of year again. Holiday tunes on the radio, twinkling lights everywhere and a hefty dose of pressure to deliver the "perfect" Christmas. But what happens when you're juggling debt, young kids and the harsh reality that you're barely making ends meet? That's where Joshua found himself when he called into The Ramsey Show.&nbsp;
In a video posted in December titled, "Buy My Kids Christmas Gifts or Pay Off Debt?", <a href="https://www.benzinga.com/personal-finance/24/12/42488891/dave-ramsey-scolds-broke-61-year-old-with-no-money-who-splurged-on-a-26000-tractor-quit-blaming-dumb-stuff-on-being-a-country-girl">Dave Ramsey</a> and his co-host daughter, Rachel Cruze, didn't hold back.
At just 24 years old, Joshua – a medically retired military veteran – shared a tough predicament. "We ran into some financial hardship … and with Christmas coming up, I have three young children. I'm wondering, should I sacrifice their happiness Christmas morning to continue to pay off this debt?"
Don't Miss:
<ul>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
On paper, Joshua's situation looks tight. With $1,800 in credit card debt and $4,000 in collections, plus a family of five to support, his question wasn't unreasonable. But Dave Ramsey and co-host Rachel Cruze didn't sugarcoat their advice.
"Absolutely, you need a job," Dave said point-blank. Joshua, currently in school full-time, explained he was studying business administration with a focus on project management. His plan was to complete his degree without working for the next four years. Meanwhile, his wife stays home with their three young kids, including a newborn.
That plan didn't fly with Dave. "I worked 40 to 60 hours a week while I was going to school," he reminded Joshua. The bottom line? While education is important, it can't come at the expense of providing for your family.
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
Joshua mentioned he's earning around $6,000 a month from his military pension, but as Dave pointed out, "You can save up the money for Christmas by working during this month." The advice? Start driving for Uber, delivering with Grubhub or picking up any available gig.
Rachel chimed in with a mom's perspective, reassuring Joshua – and every parent out there – that <a href="https://www.benzinga.com/personal-finance/24/12/42317960/warren-buffett-used-to-gift-loved-ones-10000-cash-for-christmas-but-switched-to-stocks-with-a-note-cash-them-in-or-hold-onto-them">Christmas doesn't have to be expensive</a> to be meaningful. "Kids are so low maintenance," she said. "Go so cheap … they just want the experience of opening gifts."
She also shared a personal anecdote: "We spent all this stinking money on Christmas and Uncle Mac went to the dollar store, spent 20 bucks and was the biggest hit. All kids care about is opening something!"
Dave added with his usual wit, "The newborn doesn't even know it's Christmas. Feed them, change their diaper and they're a happy puppy."
Trending: Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a>
Beyond Christmas, the real focus was on Joshua's long-term plan. "You only need $5,800 to be debt-free," Dave emphasized. "You could have that by March." He urged Joshua to keep working after the holidays, balancing his job with his online classes to dig out of debt and set his family up for financial success.
And for parents everywhere, Rachel left a crucial reminder: "Your kids want you. The stuff doesn't matter. Create experiences, not expenses."
Joshua's story is a wake-up call for anyone feeling the pressure of the holiday. Christmas doesn't have to come with a <a href="https://www.benzinga.com/news/24/12/42392068/elon-musks-ex-wife-says-he-forgot-to-buy-her-a-christmas-gift-but-when-he-realized-he-walked-barefoot-in-a-snowstorm-to-find-flowers">price tag you can't afford.</a> Whether delivering pizzas or picking up extra shifts, there's always a way to make it work without sacrificing your financial health. And remember, your kids will cherish the memories you create far more than the stuff you buy.
So this year, keep it simple. Ride bikes, bake cookies or hit the dollar store for a garbage bag full of joy. Your wallet – and your kids – will thank you.
Read Next:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>

'Buy My Kids Christmas Gifts Or Pay Off Debt?' – Young Dad Of 3 Asks Dave Ramsey If He Should 'Sacrifice Their Happiness' Christmas Morning?

Mark Cuban, the serial entrepreneur and investor best known for his role on &#8220;Shark Tank,&#8221; had a surprisingly simple goal when he became a millionaire: avoid <a href="https://www.benzinga.com/news/24/12/42380812/mark-cuban-shares-the-one-thing-he-splurged-on-after-striking-it-rich-im-not-a-big-spender">spending all his money at once</a>.
What Happened: After selling his software company, MicroSolutions, for $6 million in 1990 and pocketing about $2 million after taxes, Cuban adopted a conservative investment approach to preserve his newfound wealth.
"I want you to invest for me like a 60-year-old. I don't want you to invest like I'm young, because I want to live off this for a long time," Cuban recalled telling his broker at the time and <a href="https://www.youtube.com/watch?v=oEK2063FPLw">shared</a> this in a recent interview.
This strategy, along with his frugal lifestyle, allowed him to safeguard his wealth while still enjoying occasional splurges.
Cuban's modest upbringing as the son of an automobile upholsterer near Pittsburgh shaped his cautious approach to money. 
Even after becoming a millionaire, he lived below his means, buying "the worst house in the best neighborhood" and steering clear of flashy cars. 
"By the time I sold MicroSolutions, I had just bought the worst house in the best neighborhood, but I wasn't big into that. I wasn't big into cars. I wanted to live like a student and just have fun," Cuban said. 
However, one notable indulgence was a $125,000 lifetime pass with American Airlines, which he used to "party like a rock star" across cities with his friends.
Also Read: <a href="https://www.benzinga.com/news/24/10/41196856/heres-how-mark-cubans-drunken-splurge-of-125-000-turned-into-a-profitable-investment">Mark Cuban Drunkenly Bought A $125,000 Lifetime Flight Pass And Turned It Into A Profitable Investment</a>
His financial perspective shifted dramatically in 1999 when he sold his second company, Broadcast.com, for $5.7 billion. The windfall gave Cuban the freedom to take more significant risks, a mindset he has carried into his investing career. 
Cuban has said that smart risks are essential to building wealth, reflecting his evolution from a cautious millionaire to a bold billionaire.
Today, Cuban focuses on his family and running Cost Plus Drugs, his pharmaceutical startup aimed at lowering prescription drug costs. While his days of lavish partying are behind him, he remains dedicated to making a positive impact. "I think less about making money and more about direction and&#8230;benefit[ing] as many Americans as I can," Cuban said during the interview.
Read Next
<a href="https://www.benzinga.com/news/24/11/41703723/mark-cubans-million-dollar-advice-to-teens-if-i-were-16-again-id-start-this-lucrative-side-hustle">Mark Cuban&#8217;s Million-Dollar Advice To Teens: &#8216;If I Were 16 Again, I&#8217;d Start This Lucrative Side Hustle&#8217;</a>
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Mark Cuban's Wealth Journey: 'I Want to Live Off This for a Long Time'

These ten large-cap stocks were the best performers in the last week. Are they in your portfolio?
<ol>
<li>Teva Pharmaceutical Industries Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) stock escalated 33.88% after the company and Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) announced that primary endpoints were met in the Phase 2b trial of Duvakitug for <a href="https://www.benzinga.com//node/42531132" target="_blank" rel="noreferrer noopener">ulcerative colitis and Crohn&#8217;s disease</a>.</li>
<li>Klaviyo, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) shares surged 12.85%.</li>
<li>Olive Garden parent Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) stock rose 12.54% after the company reported better-than-expected second-quarter EPS and <a href="https://www.benzinga.com//node/42585797" target="_blank" rel="noreferrer noopener">issued an FY25 revenue outlook</a>. Several analysts raised the <a href="https://www.benzinga.com/quote/dri/analyst-ratings" target="_blank" rel="noreferrer noopener">price forecast on the stock</a>.</li>
<li>Doximity, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) shares upped 10.91%. Stephens &amp; Co. initiated coverage with an Equal-Weight rating and <a href="https://www.benzinga.com/quote/docs/analyst-ratings" target="_blank" rel="noreferrer noopener">a price forecast of $55</a>.</li>
<li>Birkenstock Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>) shares increased 9.70% after the company reported better-than-expected fourth-quarter financial results and issued FY25 guidance. Several analysts raised <a href="https://www.benzinga.com//node/42599431" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Jabil Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBL#NYSE">JBL</a>) stock upped 7.30% after the company reported better-than-expected <a href="https://www.benzinga.com//node/42553094" target="_blank" rel="noreferrer noopener">first-quarter EPS and revenues</a>. Several analysts raised <a href="https://www.benzinga.com/quote/jbl/analyst-ratings" target="_blank" rel="noreferrer noopener">the price forecast on the stock</a>.</li>
<li>Neurocrine Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIX#NASDAQ">NBIX</a>) stock rose 6.88%. The FDA approved Crenessity (crinecerfont) capsules and oral solution as an adjunctive treatment to glucocorticoid replacement to control androgens in adult and pediatric patients four years of age and older with <a href="https://www.benzinga.com//node/42508449" target="_blank" rel="noreferrer noopener">classic congenital adrenal hyperplasia (CAH).</a></li>
<li>GameStop Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) stock was up 6.54% last week, continuing strength from Q3 earnings.</li>
<li>Dr. Reddy&#8217;s Laboratories Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDY#NYSE">RDY</a>) stock increased 6.29%.</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>) shares upped 6.13% last week.</li>
</ol>
Photo by Sundry Photography via Shutterstock

BIRK

CHWY

DOCS

KVYO

NBIX

Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?

Elon Musk wasn't always the polarizing figure we see today in climate discussions. Once <a href="https://www.benzinga.com/news/24/04/38131745/cathie-wood-hails-elon-musks-visionary-impact-hes-transforming-the-world-saving-humanity-from-itself">celebrated</a> as a green-tech pioneer, Musk was vocal about the urgent need to combat climate change. In 2006, he described Tesla's mission as a way to "help expedite the move from a mine-and-burn hydrocarbon economy toward a solar electric economy." In 2015, he warned of the devastating consequences of delaying this transition. &#8220;The worst case,&#8221; he said, &#8220;is more displacement and destruction than all the wars in history combined.&#8221;
At the time, Musk painted a grim picture of the future if humanity failed to act. He specifically talked about the dangers of rising sea levels, warning that <a href="https://www.benzinga.com/real-estate/24/06/39420775/coastal-home-values-plunge-as-rising-seas-erode-market-confidence">oceanfront property</a> would become &#8220;a lot less valuable&#8221; as floods destroyed homes and businesses.&nbsp;
Don't Miss:
<ul>
<li>Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
<li>Deloitte's fastest-growing software company partnered with Amazon, Walmart &amp; Target announces the deadline to invest this year is 12/20. –  <a href="https://www.benzinga.com/money/mode-mobile-y2">Last Chance to get 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
In his first appearance on the Joe Rogan Podcast in 2018, Musk <a href="https://www.youtube.com/live/ycPr5-27vSI?si=uZaTXr2yTpuqmwVD&amp;t=5041">stressed</a> how strong the scientific agreement on climate change is, saying, &#8220;The scientific consensus is overwhelming. I mean, I don&#8217;t know any serious scientists – zero, literally zero – who don&#8217;t think that we have quite a serious climate risk that we&#8217;re facing.&#8221;&nbsp;
His past concerns align with findings from a Climate Central study, which revealed that nearly 650,000 parcels of oceanfront property in the U.S. currently sitting on dry land will be at least partially submerged within 30 years due to rising sea levels. This shift will <a href="https://www.benzinga.com/real-estate/24/03/37566436/the-list-of-us-cities-at-risk-of-destruction-because-of-rising-sea-levels-is-frightening-to-contempl">devastate property owners</a> and strain cities and counties that rely on property taxes to fund schools, emergency services and utilities.
See Also: This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a>
Insurance giant Swiss RE warned in 2021 that climate change could cut the world economy by $23 trillion in 2050, equivalent to 14 percent of global economic output.
Fast forward to today and Musk's rhetoric on climate change has undergone a dramatic shift. In an August conversation with Donald Trump on X, Musk downplayed the urgency of transitioning away from fossil fuels, suggesting the world has "plenty of time" to act.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Many on the left and fake news have created another hoax that Trump was "slurring his words" during the X Spaces conversation with <a href="https://twitter.com/elonmusk?ref_src=twsrc%5Etfw">@elonmusk</a> Here is the full recording proving them wrong again <a href="https://t.co/vrVcRKpu60">pic.twitter.com/vrVcRKpu60</a>
&mdash; Donald J. Trump Posts From His Truth Social (@TrumpDailyPosts) <a href="https://twitter.com/TrumpDailyPosts/status/1823821120237396379?ref_src=twsrc%5Etfw">August 14, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trending: Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl-y2"> you can become an investor for $0.80 per share today.</a>
He even described the risk of climate change as &#8220;not as high as a lot of people say it is,&#8221; framing the issue in terms of discomfort from high CO2 levels instead of catastrophic dangers scientists have long warned about. This change in attitude has left people wondering why Musk, who once called for urgent action, now seems so dismissive.
Musk's pivot has not gone unnoticed. Critics point to his embrace of right-wing politicians and climate denialism as a key factor. On X (formerly Twitter), a platform he owns, climate scientists have been leaving in droves, citing a surge in misinformation about global warming. Musk's partner in DOGE, the prospective agency <a href="https://www.benzinga.com/politics/24/11/41962372/trumps-doge-with-musk-at-the-helm-riddled-with-conflicts-of-interest-says-clinton-era-official-robert-reich">tasked with cutting government costs</a>, Vivek Ramaswamy, previously called climate change a &#8220;hoax.&#8221;
Musk&#8217;s behavior presents a conflicting image. On the one hand, Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has revolutionized the electric vehicle market and Musk&#8217;s endeavors, such as the $100 million <a href="https://www.xprize.org/prizes/carbonremoval">Xprize</a> for carbon removal, demonstrate his dedication to creative solutions. However, his personal carbon footprint undermined his message, as his private jet logged a whopping 441 flights in 2023, emitting 5,159 tonnes of CO2, according to JetSpy.
Trending: Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a>
Then there's his claim that CO2 levels would only become a problem at 1,000 parts per million (ppm), much higher than today's <a href="https://climate.nasa.gov/vital-signs/carbon-dioxide/">420 ppm</a>. Scientists quickly debunked this, explaining that society would collapse long before CO2 reached those levels, as extreme weather, rising sea levels and food shortages would create chaos. Musk's mix-up of indoor air quality standards with outdoor atmospheric CO2 measurements shows a serious misunderstanding of basic science.
This evolution – or perhaps devolution – has left many wondering: What changed? Some suggest Musk's interests now lie more in maintaining relationships in conservative circles than in driving climate advocacy. For example, President-elect Donald Trump said climate change is not "the biggest threat" and claimed it would create "more oceanfront property." Others speculate that his sprawling business empire and the demands of his ventures have pulled him away from his once-clear mission.
Read Next:
<ul>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-y2">The deadline to invest and receive your shares this year is 12/20. Join 30,000+ shareholders and invest at $0.26/share today.</a></li>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
</ul>

Before His 180 On Climate Change, Elon Musk Advocated For Action, Cautioning That Oceanfront Real Estate Values Would Plummet

Genenta Science SpA Sponsored ADR (GNTA) has released an update. Genenta Science SpA, a biotech company based in Milan, is focused on the research,...

Genenta Science Advances Biotech Endeavors

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cingulate Inc (CING – Research Report) and Genenta...

Analysts Conflicted on These Healthcare Names: Cingulate Inc (CING) and Genenta Science SpA Sponsored ADR (GNTA)

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
One of the oldest maxims in investing is that higher risk produces greater returns. That maxim holds particularly true across penny <a href="https://investorplace.com/industries/healthcare/biotech/">biotech stocks.</a> Developing therapeutics to cure diseases is a complex business model fraught with the potential to fail at many points.&nbsp;



Developmental and regulatory time frames are long, introducing multiple potential points of failure. The capital necessary for research and development is substantial. So on and so forth. The result is that many&nbsp;upstart biotech firms fail to commercialize, taking their equity down in the process.



Those firms that make it through and reach commercialization are rewarded with the spoils of success. They pay shareholders handsomely with returns that can turn a small investment into a fortune. The firms discussed below still have reasonable chances of commercialization and the potential to reward investors handsomely. Even if they don&rsquo;t ultimately reach success, they can still reward investors handsomely as they pass milestones in the development process.



<h2>FibroGen (FGEN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-300x169.png" alt="Medical technology network team meeting concept. Doctor hand working smart phone modern digital tablet laptop computer graphics chart interface, sun flare effect photo, PTE"><div>Source: everything possible / Shutterstock.com</div></div>FibroGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) continues on the path toward commercialization for multiple drugs, targeting multiple diseases. The firm&rsquo;s leading candidate drugs include Pamrevlumab, Roxadustat and several other oncology therapeutics.



Pamrevlumab is currently in Phase 3 clinical trials for the treatment of a certain form of pancreatic cancer. It is also concurrently being studied in phase 2/3&nbsp;clinical studies for metastatic pancreatic cancer. Roxadustat is a drug that induces the production of red blood cells and is approved in multiple countries for use in treating anemia in chronic kidney disease populations. A supplemental New Drug Application (sNDA) has been submitted in China for the drug. It has been accepted for review by the China Health Authority.&nbsp;



One of the more compelling aspects of FibroGen as an investment in financial performance. During the <a href="https://www.globenewswire.com/news-release/2024/05/06/2876129/33525/en/FibroGen-Reports-First-Quarter-2024-Financial-Results.html">first quarter, revenues</a> approached $56 million, up from $36 million a year earlier. The increased revenues allow the company to slash its net losses from $76.7 million to just below $32 million this quarter. Shares currently trade for $1.30 with a <a href="https://stockanalysis.com/stocks/fgen/forecast/">consensus target price of $5</a> and analyst targets ranging as high as $11.



<h2>Nuvectis Pharma (NVCT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/biopharma-1600-300x169.jpg" alt="Illustration of a biopharma company. Doctor standing in front of various medical icons."><div>Source: Billion Photos / Shutterstock</div></div>Nuvectis Pharma (NASDAQ:<a href="https://investorplace.com/stock-quotes/nvct-stock-quote/">NVCT</a>) is another oncology-oriented biotech stock. It&rsquo;s particularly interesting as a potential investment because while it is in the pre-revenue stages, it is also highly regarded and priced higher than one might expect.



Shares currently trade for $6.21, which is quite high for a pre-revenue biotech firm. Those shares have coverage from a single analyst who expects their value to rise to $22 in the future. Investors who look at the company&rsquo;s financial statements will see that it is basically treading water. NVCT has more than $19 million in liquidity and loses roughly $4 million a quarter on R&amp;D and administrative costs.&nbsp;



The reason for optimism surrounding Nuvectis Pharma is simple: Lead candidate drug <a href="https://www.globenewswire.com/news-release/2024/05/07/2876700/0/en/Nuvectis-Pharma-Inc-Reports-First-Quarter-2024-Financial-Results-and-Business-Highlights.html">NXP800 has been granted</a> fast-track designation by the FDA in platinum-resistant ARID1a-mutated ovarian cancer. It&rsquo;s currently in Phase 1b studies and has the potential to pass through multiple milestones moving forward that, if successful, will reward investors with strong and immediate returns.



<h2>Relmada Therapeutics (RLMD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600-300x169.png" alt="OLK Stock. Modern Medical Research Laboratory: Two Scientists Wearing Face Masks use Microscope, Analyse Sample in Petri Dish, Talk. Advanced Scientific Lab for Medicine, Biotechnology. Blue Color. KZR stock. RSLS stock. Best Biotech Stocks to Buy"><div>Source: Gorodenkoff / Shutterstock.com</div></div>Relmada Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rlmd-stock-quote/">RLMD</a>) is one of many promising late-stage biotech firms developing therapeutics to address diseases of the central nervous system. Those diseases include disorders with high unmet needs including major depressive disorder (MDD), a primary focus of the firm.



REL-1017 is one of the company&rsquo;s lead candidate drugs. The drug is in late-stage development for the treatment of MDD. It is being studied to understand the potential of the drug as a fast-acting, once-daily antidepressant treatment.&nbsp;It is currently being studied in two Phase 3 double placebo-controlled studies.



The company also acquired the rights to a psilocybin and derivatives program&nbsp;in 2021. That program has been rebranded as REL-P11 and is being studied for its efficacy in both neurogenesis and in ameliorating the effects of neurodegenerative conditions.&nbsp;



Psilocybin and other psychoactive drugs are currently a hot area of research. Although Ralmada Therapeutics is in the pre-revenue stages and shares trade for $3.04, the sole analyst with coverage believes those shares could be worth as much as $25 in the future.



<h2>Anixa Biosciences (ANIX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600-1-300x169.jpg" alt="A scientist holds a test tube while it is in a container"><div>Source: Shutterstock</div></div>Anixa Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/anix-stock-quote/">ANIX</a>) develops treatments and vaccines to address unmet needs in ovarian cancer and breast cancer. Shares currently trade for less than $3, while the single analyst with coverage believes the stock will <a href="https://www.pricetargets.com/NASDAQ/ANIX/">rise to $12 in value.</a>&nbsp;



The company very <a href="https://www.prnewswire.com/news-releases/anixa-biosciences-commences-treatment-of-fifth-patient-in-ovarian-cancer-car-t-clinical-trial-302150758.html">recently commenced treatment</a> on the 5th patient in an ovarian cancer CAR-T clinical trial. The company is enrolling patients in its first-in-human trial who were unresponsive to at least two prior therapies. Safety was confirmed in the first three-patient cohort. The company is tripling the dose in patients four and five in order to establish dosage tolerability.&nbsp;



The company also recently expanded its partnership with the Cleveland Clinic to develop cancer vaccines. That partnership aims to further the development of vaccines targeting rare and aggressive forms of breast and ovarian cancer. Anixa Biosciences will continue to be an interesting stock for investors, especially in light of strong positive news on multiple fronts.



<h2>Genenta Science (GNTA)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600-min-1-300x169.jpg" alt="an image of a microscope, NEXI stock"><div>Source: Shutterstock</div></div>Let&rsquo;s begin discussing Genenta Science (NASDAQ:<a href="https://investorplace.com/stock-quotes/gnta-stock-quote/">GNTA</a>) stock in relation to its safety as an investment overall. Readers have noticed that multiple recommendations above have only one analyst rating. I don&rsquo;t have to explain why that introduces a lot of risk overall. The thing I want to note about Genenta Science is that it has <a href="https://stockanalysis.com/stocks/gnta/forecast/">two target prices,</a> one at $15 and the other at $25. Thus, the consensus price is $20. Genenta Science shares trade at $3.30.



While the company is attractive for its raw return potential, I should also note that there are a lot of unknowns with this company. It is an Italian company and doesn&rsquo;t provide a lot in the way of information. It&rsquo;s a lot easier to find updates on domestic companies. The information we do have is a<a href="https://ir.genenta.com/static-files/db77523d-9bdf-47bd-8120-02eb11e0d7df"> financial report dating from the end of 2023.</a> It simply shows the company is not producing much in the way of revenues.



The stock offers so much potential because the company is developing a stem cell platform for the safe treatment of solid tumors. It has <a href="https://www.globenewswire.com/news-release/2024/02/08/2825783/0/en/Genenta-Demonstrated-Reprogramming-of-the-Tumor-Microenvironment-in-GBM-Patients-Paving-the-Way-for-Innovative-Treatments-of-Solid-Tumors.html">demonstrated the potential</a> to reprogram the cells of glioblastoma patients.&nbsp;



<h2>Affimed (AFMD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/02/red-blood-cells-300x169.jpg" alt="3d rendering red blood cells in vein"><div>Source: Phonlamai Photo / Shutterstock.com</div></div>Affimed (NASDAQ:<a href="https://investorplace.com/stock-quotes/afmd-stock-quote/">AFMD</a>) continues to develop therapeutics for the treatment of lymphoma, a grouping of blood cancers that originate in the lymphatic system.



The stock is interesting for a number of reasons both operational and developmental. The company reduced <a href="https://www.globenewswire.com/news-release/2024/03/28/2853795/0/en/Affimed-Reports-2023-Financial-Results-and-Operational-Progress.html">its workforce by 50% in 2023</a> in an effort to streamline operations.



AFMD is redirecting its resources to three lead candidate programs following the restructuring. That leads me to my next point: The company is doing well from a developmental perspective. Each of those three candidate programs progressed in 2023. Affimed awaits further data readouts from those programs in Q2 and expects dose escalation. That implies current safety and will be used to establish the upper tolerability for those respective programs.&nbsp;



As with any penny biotech stock, failure is a distinct possibility. However, Affimed is well regarded and benefits from a <a href="https://stockanalysis.com/stocks/afmd/forecast/">consensus target price of $32.</a> It currently trades for just over $4.&nbsp;



<h2>Lipocine (LPCN)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/biotech1600d-300x169.jpg" alt="Image of two scientists in lab coats studying results in a lab. best biotech stocks to buy"><div>Source: Shutterstock</div></div>Lipocine (NASDAQ:<a href="https://investorplace.com/stock-quotes/lpcn-stock-quote/">LPCN</a>) stock trades for $6.89 but is expected to rise to $33. Like so many other stocks on this list, Lipocine only has coverage from one analyst. That introduces risk to what is already a risky biotech stock. However, that&rsquo;s the game investors must be willing to play in the risk-fueled world of pharma stock&nbsp;investing.



As you may have guessed by the firm&rsquo;s name, Lipocine does work in the obesity management space. Candidate drug Lpcn2401 is currently in Phase 2 studies and is showing promise in reducing obesity in patients with at least one co-related morbidity.



However, the company is also developing treatments outside of the weight loss realm. Those programs span disease areas, including postpartum depression, cirrhosis, essential tremors and testosterone replacement therapy.&nbsp;



What&rsquo;s particularly good about the company is that it actually produced positive net income in the most recent quarter. Lipocine <a href="https://www.prnewswire.com/news-releases/lipocine-announces-financial-results-for-the-first-quarter-ended-march-31-2024-302140431.html">reported $3.5 million in net income</a> in the first quarter, reversing a $3.9 million net loss 12 months prior.



On <a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a> and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com&rsquo;s writers disclose this fact and warn readers of the risks.



Read More: <a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/">Penny Stocks &mdash; How to Profit Without Getting Scammed</a>



On the date of publication, Alex Sirois did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/"> Publishing Guidelines.</a>
<div>Alex Sirois is a freelance contributor to InvestorPlace whose personal stock investing style is focused on long-term, buy-and-hold, wealth-building stock picks. Having worked in several industries from e-commerce to translation to education and utilizing his MBA from George Washington University, he brings a diverse set of skills through which he filters his writing.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/05/7-penny-biotech-stocks-to-triple-your-investment/">7 Penny Biotech Stocks to Triple Your Investment</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Penny Biotech Stocks to Triple Your Investment

Maxim Group analyst Jason McCarthy maintained a Buy rating on Genenta Science SpA Sponsored ADR (GNTA – Research Report) yesterday and set a price ...

Buy Rating Affirmed for Genenta Science Amid Promising Developments in Gene Therapy Trials

Comments

Genenta Science

Genenta Science (GNTA) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga